Reduced survival of apolipoprotein E4 homozygotes in Down's syndrome?

J. L. Holder, R. A. Habbak, G. D. Pearlson, E. A. Aylward, M. Pulsifer, A. C. Warren

Research output: Contribution to journalArticlepeer-review

Abstract

An increased frequency of apolipoprotein E (ApoE) allele ε4 has been established in Alzheimer's disease (AD) subjects. Based on the observation that all individuals with Down's syndrome (DS) develop the neuropathology of AD by the age of 40 years we sought to determine whether ApoE genotype affected the clinical symptoms of AD. Unexpectedly, we failed to find any ε4 homozygotes, as have other published studies: this is highly significant statistically. We suggest this is due to decreased survival or, less likely, embryonic lethality of ε4 homozygotes in DS.

Original languageEnglish (US)
Pages (from-to)2455-2456
Number of pages2
JournalNeuroreport
Volume7
Issue number15-17
DOIs
StatePublished - 1996

Keywords

  • ApoE
  • Down's syndrome

ASJC Scopus subject areas

  • Neuroscience(all)

Fingerprint Dive into the research topics of 'Reduced survival of apolipoprotein E4 homozygotes in Down's syndrome?'. Together they form a unique fingerprint.

Cite this